<?xml version="1.0" encoding="UTF-8"?>
<p>Owing to concerns about oral corticosteroids, other forms of treatment for viral wheezing have been examined in preschool children. A study in 1- to 6-year-old ­children showed a benefit of episodic high-dose inhaled steroids with viral RTI and wheezing (
 <xref ref-type="bibr" rid="CR31">31</xref>), though some adverse effects on growth were noted. The effectiveness of a LTRA, montelukast, was examined in a study of 2–5 year olds with a history of intermittent asthma. This study showed a reduction of typically viral-induced asthma exacerbations in children given the LTRA as a daily controller (
 <xref ref-type="bibr" rid="CR32">32</xref>). Both inhaled corticosteroids and LTRAs are options to control chronic asthmatic wheezing in this age group (
 <xref ref-type="bibr" rid="CR17">17</xref>).
</p>
